Medical research

New paradigm for treating 'inflammaging' and cancer

Intermittent dosing with rapamycin selectively breaks the cascade of inflammatory events that follow cellular senescence, a phenomena in which cells cease to divide in response to DNA damaging agents, including many chemotherapies. ...

Oncology & Cancer

Researchers reveal key to targeting dormant cancer cells

An international team of scientists has uncovered the unique set of genes that keeps some cancer cells dormant. Led by Associate Professor Tri Phan and Professor Peter Croucher at the Garvan Institute of Medical Research ...

Oncology & Cancer

Protein may be key to cancer's deadly resurgences

Tumor recurrence following a period of remission is the main cause of death in cancer. The ability of cancer cells to remain dormant during and following therapy, only to be reactivated at a later time, frequently with greater ...

Oncology & Cancer

Cancer cells have Alzheimer's disease, too

A study published today by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine describes that certain proteins playing a role in cancer progression and metastasis are ...

Oncology & Cancer

Team identifies a switch that may help target dormant cancer cells

A study by scientists at the University of Arizona and the University of Pittsburgh may hold the key to targeting dormant—or inactive —cancer cells, which are resistant to chemotherapy and other treatments. The results ...

Oncology & Cancer

Why cancer cells go to sleep—the mystery of cancer dormancy

Cancer has always been thought of as something that grows rapidly and uncontrollably, but this view may be wrong. New evidence suggests that cancer alternatively uses the "accelerator" and the "brake" in order to survive.

page 2 from 4